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Background: The large amounts of data generated by genomics, transcriptomics and proteomics have increased
our understanding of the biology of Anaplasma marginale. However, these data have also led to new assumptions
that require testing, ideally through classical genetic mutation. One example is the definition of genes associated
with virulence. Here we describe the molecular characterization of a red fluorescent and spectinomycin and
streptomycin resistant A. marginale mutant generated by Himar1 transposon mutagenesis.
Results: High throughput genome sequencing to determine the Himar1-A. marginale genome junctions established
that the transposon sequences were integrated within the coding region of the omp10 gene. This gene is arranged
within an operon with AM1225 at the 5’ end and with omp9, omp8, omp7 and omp6 arranged in tandem at the 3’ end.
RNA analysis to determine the effects of the transposon insertion on the expression of omp10 and downstream genes
revealed that the Himar1 insertion not only reduced the expression of omp10 but also that of downstream genes.
Transcript expression from omp9, and omp8 dropped by more than 90% in comparison with their counterparts in
wild-type A. marginale. Immunoblot analysis showed a reduction in the production of Omp9 protein in these
mutants compared to wild-type A. marginale.
Conclusions: These results demonstrate that transposon mutagenesis in A. marginale is possible and that
this technology can be used for the creation of insertional gene knockouts that can be evaluated in natural
host-vector systems.Background
Anaplasma marginale is a tick-borne and obligate intra-
cellular bacterium that causes bovine anaplasmosis, a
disease that has gained particular attention due to the
considerable economic losses for the cattle industry
[1-4]. Onset of clinical disease is mainly characterized by
a severe hemolytic anemia [1,2]. Cattle that survive acute
infection become carriers of A. marginale and organisms
can be transmitted to susceptible cattle mechanically or
by tick bite [2]. A. marginale persists in carrier cattle
because of its capability to subvert the immune system
using antigenic variation in which different variants of* Correspondence: crosbyl@ufl.edu
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unless otherwise stated.outer membrane proteins such as Msp2 and Msp3 are
expressed [5-8].
Work on the development of a preventive vaccine
against this disease began in the early 1900’s with the
isolation of A. marginale subsp. centrale [9,10]. This less
virulent strain, originally from South Africa, is used for
immunization of cattle in Africa, Australia, South America
and the Middle East and remains the most widely-used
and practical vaccine against bovine anaplasmosis [9-11].
This vaccine is not approved in the United States because
of the risk of transmitting contaminant blood-borne
pathogens that will infect cattle [1]. Recently, compara-
tive genomic studies demonstrated that proteins that
are conserved in US strains were not conserved in A.
marginale subsp. centrale [10-12].
Different vaccination methods have been developed
for the control of bovine anaplasmosis that range fromLtd. This is an Open Access article distributed under the terms of the Creative
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binant protein vaccines [9]. But A. marginale derived
from cell culture, killed organisms and DNA vaccines in-
duce only partial protection [13-15]. Immunization trials
using outer membrane proteins or a complex of linked
or unlinked outer membrane proteins of A. marginale
derived from erythrocytes have demonstrated good pro-
tection against high bacteremia, anemia and homologous
strain challenge [16-20]. However, to promote long last-
ing protection, several immunization boosts may be re-
quired and in addition to this, production and purification
of these components is time-consuming and expensive.
The increased use of molecular approaches such as
whole genome, RNA sequencing, proteomics and com-
parative genomics of A. marginale has identified poten-
tial virulence-associated targets that can be altered or
removed by reverse genetics techniques [12,21-25]. This
could allow the creation of attenuated organisms that
have reduced pathogenicity but still elicit cellular and
antibody responses that stimulate immunity without caus-
ing disease. Consequently the development of genetic
tools to transform A. marginale and generate in-vitro gene
knockouts, or insertional mutants that can be tested
for attenuation in their in-vivo environment is of great
significance.
One way to create insertional mutations in pathogenic
bacteria is via transposon mutagenesis, in which a library
of recombinant bacteria containing different transposon
insertions can be created, allowing for the screening
of mutant strains with diverse phenotypes [26,27]. The
Himar1 transposon is a non-replicative class II DNA
transposon that is a member of the Tc1/mariner family
and is often used for the creation of insertional mutants.
Since these types of transposons are horizontally trans-
ferred between species, they do not have host restricted
functions, making them suitable for use in a wide-range
of eukaryotic and prokaryotic hosts [27,28]. In addition
to this, the Himar1 transposon does not have DNA tar-
get specificity since it is integrated randomly in TA di-
nucleotide sites [28-30]. Because of these advantages,
transposon mutagenesis using this system has been suc-
cessfully developed in other tick-borne pathogens such
as Rickettsia rickettsii, Coxiella burnetii, Borrelia burg-
dorferi, Francisella tularensis, Ehrlichia chaffeensis and
Anaplasma phagocytophilum [31-40]. These previous re-
sults suggest that this system could be useful for the
transformation of A. marginale.
Nevertheless, previous attempts to transform A. mar-
ginale by transposon mutagenesis were not successful.
Previously, the Himar1 transposon and transposase were
delivered in two separate vectors into A. marginale which
resulted in the isolation of green fluorescent and antibiotic
resistant bacteria. However molecular characterization of
these recombinant organisms established that the entireplasmid carrying the transposon sequences was inte-
grated into the A. marginale chromosome by a single
crossover homologous recombination mechanism instead
of the classical cut and paste mechanism of transposition
[41]. Therefore, we wanted to evaluate first, if classical
transposon mutagenesis using the Himar1 transposon sys-
tem is achievable in A. marginale, and second, if trans-
poson mutagenesis using this system, is useful for the
creation of insertional knockout mutations.
Results
Transformation of Anaplasma marginale by transposon
mutagenesis
Attempts to transform A. marginale by transposon muta-
genesis using the Himar1 transposon/transposase system
delivered in two separate plasmids were not successful.
The probability that two plasmids are introduced at once
into A. marginale organisms could be very low, especially
when viability in the extracellular environment might be
highly compromised, resulting in a low fraction of cells
competent to take up DNA.
Therefore in order to promote transposon mutagenesis
in these bacteria, the transposase was provided in cis
with the Himar1 transposon sequences (R. F. Felsheim
unpublished data). The pHimarcisA7mCherry-SS con-
tains the hyperreactive allele A7 transposase and the
Himar1 TIR flanking the mCherry reporter gene and the
aadA gene, which confers resistance against spectino-
mycin and streptomycin. Expression of the transpo-
sase and the reporter and antibiotic selection genes
is driven by the A. marginale tr promoter [41,42]
(Figure 1A). Antibiotic selection pressure of electro-
porated bacteria with this construct resulted in the
isolation of red fluorescent and antibiotic resistant
bacteria (Figure 1B).
Mapping of transposon insertion within the A. marginale
chromosome
We used Roche/454 and Illumina high-throughput
genome sequencing to determine: 1) the location of
plasmid sequences within the A. marginale chromo-
some, 2) the recombination mechanism that allowed
the segregation of mutant bacteria and 3) if these re-
combinant organisms correspond to a population con-
taining insertions in different genomic locations or in
a single genome site.
Mutations produced by the integration of the Himar1
transposon into the A. marginale chromosome will
generate new junction sequences that are absent in
the wild-type. These new sequences should include
the Himar1 terminal inverted repeats (TIR) followed
by the sequence of the regions in which the trans-
poson is integrated. Based on this, the strategy that
we used to map the Himar1 insertion site involved
Figure 1 Red fluorescent A. marginale. A. Plasmid map of pHimarcisA7mCherry-SS used for the electroporation of A. marginale str.
Virginia. B. Fluorescent (left) and phase contrast/fluorescence merged (right) images, of transformed A. marginale replicating in ISE6
tick cells.
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Roche/454 and Illumina methods to two reference se-
quences, the A. marginale str. St Maries genome se-
quence (CP000030) and the Himar1 TIR sequence.
The Himar1 TIR-A. marginale genome junctions were
identified by extracting reads that aligned to the A.
marginale genome at one end and to the Himar1 TIR
at the other end.
Analysis using Illumina reads mapped the Himar1
TIR-A. marginale genome junctions into a region of
omp6 and omp10 genes. Interestingly these reads con-
tained the same mutated sequence. The omp6 and
omp10 genes share a large stretch of identity 456 nt/
459 nt (99%) [43]. The short, 100 nt length of the
Illumina reads, made it difficult to differentiate which
gene contained the Himar1 transposon. Additional
analysis using longer reads obtained on the Roche/
454 platform revealed that the Himar1 transposon
was integrated within the omp10 gene. These reads
contained a region of omp10 that is not shared with
omp6. Based on this sequencing analysis the genomic
location of the Himar1 transposon in the chromo-
some of the transformed A. marginale, is at position
245 considering 1 as the first base of the omp10 start
codon (Figure 2A).
These results were verified by PCR amplification of
gDNA from ISE6 cells infected with wild-type and
transformed A. marginale using omp6 and omp10
specific primers (Figure 2A-B). The size of omp6amplicons (492 bp) in wild-type and transformed A.
marginale was the same. However the size of the
omp10 amplicon in transformed A. marginale was in-
creased by 1836 bp when compared to the wild-type
(969 bp), indicating that the transposon was integrated
within the omp10 gene.
The genome sequence of A. marginale str. Virginia
is available only as unannotated contigs with gaps.
Therefore for our analysis we used the A. marginale
str. St Maries genome as reference. For this reason
we wanted to confirm that the transposon location in
the mutated Virginia strain was the same as the one
mapped in the reference genome. For this, combined
Roche/454 and Illumina reads were assembled and a
contig of 21,324 nucleotides identified. Alignment of
this contig with the A. marginale str. St Maries gen-
ome showed that this sequence contained part of
omp10 and upstream genes (99% identity) (Figure 3)
and that the transposon insertion site in the A. mar-
ginale str. Virginia matches the same region mapped
using the reference genome.
Further analysis of sequencing reads determined that
there is only one transposon insertion in the chromo-
some of recombinant A. marginale. The reads contain-
ing the Himar1 TIR-A. marginale junctions aligned to a
single genome site. Although these transformed or-
ganisms were not cloned, data suggest that they are
isogenic for the transposon insertion site within the
omp10 gene.
Figure 2 Mapping of Himar1 transposon insertion site. A. Location of primer pairs (AB1553-AB1554) and (AB1561-AB1562) designed to target
the omp6 and omp10 genes respectively, in wild-type (WT) and transformed A. marginale. Based on sequencing results the Himar1 sequences are
integrated in the chromosome of transformed A. marginale at nucleotide 245 after the first base of the omp10 start codon (arrows) and mCherry
and aadA (Str/Spc resistant) genes are in the opposite orientation to omp10. B. Agarose Gel electrophoresis. gDNA isolated from ISE6 tick cells
infected with wild-type (WT) and transformed A. marginale, was used as template for PCR amplification with primers shown in A. (Lane 1) 100 bp/1Kb
DNA ladder, omp6 amplicons in transformed (lane 2) and WT (lane3) A. marginale were of the same size 492 bp. The omp10 amplicon in transformed
A. marginale (lane 4) was 2805 bp, while in wild type was 969 bp (lane 5).
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locus to another is mediated by a transposase using a
cut and paste mechanism [27,30]. It has been shown
previously in other organisms that the Himar1 trans-
poson integrates preferentially into a TA site and leads
to duplication of this dinucleotide upon integration into
the target site [30]. This was found to be true also for A.
marginale. Sequencing analysis revealed that the Himar1
transposon targeted aTA dinucleotide in omp10 (Figure 4A)
and upon integration it is flanked by a TA dinucleotide
sequence (Figure 4B). Thus, the mobilization of the
Himar1 transposon into the omp10 gene of A. margin-
ale was mediated by means of the A7 transposase in a
cut and paste mechanism. This transformant of A. mar-
ginale will be referred to as omp10::himar1 mutant.
Evidence for expression of omp10 as part of an operon
We hypothesize that the transposon insertion could alter
the expression of omp10 and downstream genes. Thishypothesis is based on recent work in which the tran-
scriptome profile of A. marginale using RNAseq indi-
cated that omp10 is expressed as part of a six-gene
operon in erythrocytes of infected cattle [25]. This op-
eron includes AM1225, omp10, omp9, omp8, omp7 and
omp6 (Figure 5A).
Because of this, we wanted to determine if omp10
is expressed within a polycistronic message in
A. marginale replicating in ISE6 tick cells. The inter-
genic region between AM1225 and omp10 is 440 bp
long, while intergenic regions between omp10-9,
omp9-8, omp8-7 and omp7-6 are 62 bp, 63 bp, 64 bp
and 36 bp respectively (Figure 5A). To test whether
AM1225 through omp7 are expressed as a single
transcriptional unit, total RNA isolated from ISE6
cells infected with wild-type A. marginale was re-
verse transcribed and template cDNA was used for
amplification of intergenic regions with primers that
connect neighboring genes (Figure 5A). The omp6
Figure 3 Himar1 transposon insertion site in the A. marginale str. Virginia genome. ACT (Artemis Comparison Tool) window showing alignment
between the A. marginale genome (CP000030) used as reference, the A. marginale str. Virginia omp10::himar1 contig formed by Roche/454 and
Illumina sequencing reads and the Himar1 transposon sequences. Alignment between the A. marginale str St Maries and the omp10::himar1 mutant
shows that sequences flanking the transposon insertion site are highly similar sharing an identity of 99% (matching red band). This demonstrates
that the transposon insertion site (yellow boxes) occurred at nucleotide 245 after the first base of the omp10 start codon (black dotted line) in
the reference strain. Alignment with the Himar1 transposon sequences clearly show the insertion of these sequences in the omp10::himar1
mutant which are not present in the A. marginale str. St Maries (absence of matching band).
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previous work [43] and work in our lab showed that
transcripts from this gene are not detected in
A. marginale during infection of tick cells. Appropri-
ate size amplicons of the intergenic regions between
omp7-8, omp8-9, omp9-10 and omp10-AM1225 gene
were detected (Figure 5B), providing evidence that
these genes are transcribed as a single mRNA in
A. marginale infected tick cells.
RNA transcript analysis
Next, we determined if insertion of the Himar1 se-
quences resulted in alteration of omp10 expression and
the expression of genes downstream. For this, total
RNA from ISE6 tick cells infected with A. marginale
wild-type and omp10::himar1 mutant was reverse tran-
scribed and cDNA used as template for PCR amplifi-
cation with specific primers that were designed to
anneal to omp6, omp7, omp8, omp9, and omp10 in
wild-type and omp10::himar1 mutant respectively
(Figure 6A). The omp10, 9, 8, and 7 genes, but not
omp6, are transcriptionally active in wild-type A. mar-
ginale, although at low levels (Figure 6B). The Himar1
transposon insertion into the coding sequence of
omp10, disrupted its expression and that of omp9,
omp8, and omp7 since transcripts from these genes
were not detected in omp10::himar1 mutants ofA. marginale by this method (Figure 6B). To ensure
integrity, cDNA samples from A. marginale wild-type
and omp10::himar1 mutant were used for amplifica-
tion with specific primers of a region of 131 bp of
the 16S rRNA. Amplicons from this region were
detected in both wild-type and omp10::himar1 mu-
tant. No bands were visualized in negative controls
(Figure 6B).
Since omp10 through omp7 are expressed at low levels
in ISE6 tick cells, RT-qPCR was used to quantitatively
determine differences of expression between A. marginale
wild-type and omp10::himar1 mutant. For this, cDNA
generated from ISE6 tick cells infected with A. margin-
ale wild-type and omp10::himar mutant was used for
real time PCR amplification using primers and probes
targeting omp8, omp9, and the 3’ and 5’ ends of omp10
(Figure 7A).
In order to compare these gene expression results
between wild-type and omp10:himar1 A. marginale, Ct
values were normalized to the rpoH, msp5 and 16S
rRNA genes. Changes in expression of these genes were
calculated by the 2-ΔΔCt method, and results were
expressed as percentage of expression, with a 100% ex-
pression level being assigned to the calibrator or control
group, which in this case is wild-type A. marginale.
Although three different reference genes were used,
RT-qPCR data normalization led to similar results in
Figure 4 Characterization of Himar1 transposon insertion site. A. Artemis (genome browser and annotation tool) window showing the
A. marginale genome (CP000030) used as a reference for the location of the omp10 gene (AM1223, 1092273–1093555), and the TA dinucleotide
(1093290–1093291) at the Himar1 tn insertion site (arrow) determined by high throughput genome sequencing analysis. B. Himar1 tn insertion
into the omp10 gene was mediated by the A7 transposase in a cut and paste mechanism leading to the duplication of TA dinucleotide
sequences. A. marginale genome (underlined uppercase text, TA dinucleotide duplications (enhanced uppercase text) flanking the tn elements
(bold lowercase).
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for omp8 (97–99%), omp9 (90–99%) and omp10 3’
end (85-98%) relative to their counterparts in wild-
type A. marginale (Figure 7B). These results show
that Himar1 transposon insertion into omp10 af-
fected its expression and the expression of genes
downstream, confirming the results obtained by
RT-PCR and agarose gel electrophoresis. A second
experiment investigated the possibility of the same
effect occurring in regions of omp10 before the
Himar1 transposon insertion site. For this, a primer
and probe set was designed to anneal with a region
at the 5’ end of omp10 (Figure 7A). Even though
there was a significant reduction in the detection of
transcripts from this region (27-57%) relative to the
5’ end of omp10 in wild-type, this reduction was notas great as with the sequences located in omp10
downstream of the Himar1 transposon insertion site.Western immunoblot analysis
To determine if the decreased expression of mRNA in
genes downstream of omp10 correlated with protein
expression a Western immunoblot analysis using anti
Omp9 antibody was performed.
To compare the protein expression of omp9 between
A. marginale omp10::himar1 and wild-type, the number
of organisms per sample was quantified by qPCR using
the opag2 single copy gene to determine the copy num-
ber of A. marginale. Equal amounts (108) of organisms
of A. marginale wild-type and omp10::himar1 mutant
were loaded per lane. A. marginale str. Virginia initial
Figure 5 Intergenic regions of omp7 to AM1225 were analyzed by RT-PCR. A. Diagrammatic representation of the AM1225-omp6 operon
with AM1225, omp10, omp9, omp8, omp7 and omp6 and intergenic regions. Location of primer pairs (AB1556-AB1591), (AB1592-AB1581),
(AB1582-AB1569), and (AB1655-AB1595) designed for PCR amplification of omp7-8, omp8-9,omp9-10 and omp10-AM1225 intergenic regions
using cDNA from ISE6 cells infected with A. marginale wild-type. B. Agarose gel analysis of amplicons connecting intergenic regions from
omp7 through AM1225 (lanes 2, 5, 8, and 11). DNA was used as positive control (lanes 4, 7, 10, and 13). cDNAs from reactions with no reverse
transcriptase were used as negative controls (lanes 3, 6, 9 and 12). 100 bp/1Kb DNA ladder (lane 1).
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and negative controls respectively.
Western immunoblot showed a reduced expression of
Omp9 in omp10::himar1 A. marginale mutant compared
with wild-type (Figure 8A). The Omp9 band of 40 kDa
was present in wild-type and initial bodies but was not
detected in the mutant or using negative control anti-
body Tryp1E1 (Figure 8B). Antibody F16C1 that reacts
with major surface protein 5 (Msp5) was used as a load-
ing control. Anti-Msp5 detected this protein (19 kDa) in
wild-type and omp10::himar1 A. marginale (Figure 8C).
These results correlated with results obtained from the
RNA transcript analysis, showing that the transposon
insertion severely affected the expression of both mRNA
and protein from downstream genes such as omp9.
Discussion
The possibility of creating insertional mutations in A.
marginale not only could provide a broad understanding
of gene products required for infectivity, growth or via-
bility of this pathogen in the mammalian host and the
tick vector, but also would allow the generation of genet-
ically attenuated organisms that can be tested in vaccin-
ation trials.Here we report that transposon mutagenesis using the
Himar1 transposon/transposase system for A. marginale
is achievable and it could be useful for creating inser-
tional mutations in these organisms. High throughput
genome sequencing analysis for the characterization of
these transformants established that transposon se-
quences are integrated within the omp10 gene of the A.
marginale chromosome and its mobilization within this
gene was mediated by the transposase in a cut and paste
mechanism, since i.) the transposon sequences were
integrated within a TA dinucleotide site ii.) upon inte-
gration of the transposon, this sequence was duplicated
and is found flanking the transposon TIR at the junc-
tions with the A. marginale genome and iii.) sequences
from the delivering vector outside the transposon were
not found.
Although these omp10::himar1 mutant organisms were
not cloned, they are isogenic for the transposon insertion
within the omp10 because all the sequencing reads con-
taining the transposon-A. marginale genome junctions
aligned to the same genome site in the A. marginale/St.
Maries reference genome sequence (CP000030). Possible
reasons include transposon insertion into other genome
regions that are essential for growth in tick cells, or
Figure 6 Transcriptional analysis of the effect of the insertion of the Himar1 transposon within the omp10 gene by RT-PCR. A. Binding
sites of primers (AB1553-AB1554), (AB1555-AB1556), (AB1591-AB1592), (AB1559-AB1560), and (AB1561-AB1562), designed to amplify transcripts on
omp6, 7, 8, 9 and 10, respectively, in wild-type (WT) and omp10::himar1 mutant. Complementary DNA from WT and omp10::himar1 mutant grown
in ISE6 tick cells was used for PCR amplification for omp6 through 10 with specific primers to evaluate gene expression. B. Agarose gel analysis of
PCR products for omp6 through 10 in omp10::himar1 mutant (lanes 2, 8, 14, 20, and 26). PCR products for omp6 through 10 in WT (lanes 5, 11, 17,
23, and 29). Genomic DNA was used as positive control (lanes 4, 7, 10, 13, 16, 19, 22, 25, 28, and 31). Complementary DNA from reactions
without reverse transcriptase were used as negative controls (lanes, 3, 6, 9, 12, 15, 18, 21, 24, 27, and 30). 100 bp/1Kb DNA ladder lane 1).
16S rRNA (AB1572-AB1573) was used as an internal control to ensure integrity of cDNA (lanes 32–37).
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recovery of these mutants. This suggests that further
optimization is required to improve transformation effi-
ciencies and for more rapid identification and separation
of mutants before they are visible in cultures.
The omp10 gene is part of the omp1 through omp14
clusters, members of the msp2 superfamily that corres-
pond to the pfam01617 family of bacterial surface anti-
gens [21]. Deep sequencing of cDNA generated from
total RNA of erythrocytes infected with A. marginale
identified 70 putative operon arrangements. One con-
tained omp10 transcribed as part of an operon of six
genes with AM1225 at the 5’ end and with omp9, omp8,
omp7 and omp6 arranged in tandem at the 3’ end [25].
In order to have a better understanding of the effects of
the transposon insertion in omp10 on adjacent genes it
was important to determine if omp10 is also expressed
as part of a polycistronic message in A. marginale repli-
cating in tick cell cultures.
RT-PCR of intergenic regions between omp7-8, omp8-9,
omp9-10 and omp10-AM1225 provided evidence that
omp10 is transcribed within a polycistronic message in A.
marginale infected tick cells. However transcripts of
omp6 were not detected. Similar results in which omp6expression was not detected in A. marginale infected
IDE8 tick cells and in tick midguts were obtained by
others previously [43]. A lack of omp6 transcripts sug-
gests that this gene may not be expressed in tick cells
or only at very low levels. It has been shown that, in
bacteria with reduced genomes such as Mycoplasma
pneumoniae, gene members of an operon are not al-
ways expressed at the same levels and those genes distal
from the promoter may have lower expression [44].
RT-PCR and relative gene expression experiments
demonstrated that insertion of Himar1 into omp10 at
nucleotide 245 from the start of the ORF altered the
sequence of this gene. This resulted in the loss of its
expression since there was a significant reduction in the
detection of transcripts from this gene when compared
with the expression of omp10 transcripts from wild-type
A. marginale.
It has been shown that in bacteria production and/or
stability of mRNA in regions downstream of a trans-
poson insertion is greatly reduced, to the point where
very little mRNA corresponding to this region can be
isolated [45]. Insertion of Himar1 within a gene can
affect the expression of neighboring genes, as shown in a
variety of bacteria and especially in other tick-borne
Figure 7 Relative gene expression by RT-qPCR. A. location of binding sites for primers and probes designed to target omp8 (1. AB1591, 2. AB1592,
3. AB1593), omp9 (4. AB1581, 5. AB1582, 6. AB1583), 3’ end of omp10 (7. AB1569, 8. AB1570, 9. AB1571), and the 5’ end of omp10 (10. AB1594, 11. AB1595,
12. AB1596). B. Bar lengths represent the percentage of expression of omp8, omp9, 3’ end of omp10 and 5’ end of omp10 in A. marginale wild-type
(red bars) and omp10::himar1 mutant (blue bars). msp5, rpoH and 16S rRNA were used as reference genes for data normalization. Changes in
expression of these genes were calculated using the 2-ΔΔCtmethod.* Significant differences (P < 0.05) were calculated as described in materials
and methods.
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the Himar1 insertion on the expression of genes down-
stream and upstream of omp10 in omp10::himar1 A.
marginale. Results showed that the transcriptional activ-
ities of omp9 and omp8 were negatively influenced by
the insertion of the Himar1 within omp10 since detectionof transcripts was significantly decreased in relation to
wild-type omp9 and omp8.
Although the transcription activity of regions upstream
of the transposon insertion site at the 5’ end of omp10
dropped significantly in relation to wild-type A. marginale,
it was not as severe as with genes downstream of omp10.
Figure 8 Immunoblotting of omp10::himar1 mutant and WT A. marginale using the specific monoclonal antibody Omp9. Proteins from
equal amounts of host cell-free wild-type (WT) and omp10::himar1 A. marginale were separated by SDS-PAGE gel electrophoresis. Immunoblot PVDF
membranes of transferred proteins were reacted with monoclonal antibodies and reactions were visualized by chemiluminescence. A. Monoclonal
antibody Omp9 (4 μg/ml) with specificity to Omp9 protein (40 kDa) (black arrow). B. Negative control, monoclonal Tryp1E1 (4 μg/ml) (exhibits
specificity for a variable surface glycoprotein of Trypanosoma brucei. C. Monoclonal F16C1 (2 μg/ml), reacts with the Msp5 (19 kDa) (blue arrow) protein
of A. marginale, was used as loading control. A. marginale str. Virginia and uninfected ISE6 cells were used as positive and negative controls respectively.
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strand is found in the opposite orientation to omp10, so it
might be possible for transcription to read through the
Himar1 sequences and produce anti-sense transcripts that
could reduce expression of sequences upstream of omp10,
but to demonstrate this further characterization is required.
Western immunoblot analysis showed that the trans-
poson insertion into omp10 markedly reduced protein
expression of omp9 in the omp10::himar1 mutant A.
marginale when compared to wild-type, corroborating
that both mRNA and protein expression from genes
downstream of omp10 were disrupted.
The evidence presented here suggests that these genes are
not essential for growth of A. marginale in tick cell culture.
Significant work on the possible interactions between the
expressed proteins in different host environments has accu-
mulated and offers important clues about the possible pheno-
typic effects of the disruption of these genes in A. marginale.
For example omp7, omp8, omp9 and omp10 are differentially
expressed in tick and mammalian cells with lower levels in
tick midgut and cultured tick cells [43]. Detection of proteins
from these genes has been reported [43,47,48]. Omp7, Omp8
and Omp9 are conserved during tick transmission and in
acute and persistently infected cattle [43]. Characterization of
the repertoire of outer membrane surface proteins by mass
spectrometry identified Omp10 and Omp7 as immunogenic
in cattle [47]. Proteome analysis using crosslinking and liquid
chromatography–mass spectrometry (LC-MS/MS) to deter-
mine the composition and topological organization of surface
proteins in A. marginale in mammalian and tick cells isolated
a large protein complex and analysis demonstrated thatOmp7, Omp8 and Omp9 are arranged in the outer mem-
brane as near neighbors to Msp2, Msp3, Msp4, Omp1,
Opag2, Am779, Am780, Am1011, Am854 and VirB1 in
A. marginale isolated from erythrocytes [18]. In contrast a
similar sized large protein complex in A. marginale isolated
from tick cells was formed only by Msp2, Msp3, Msp4,
Am778 and Am854. Although Omp7, Omp8 and Omp9
were expressed they did not seem to be localized to the sur-
face, suggesting a possible re-arrangement in the topology of
the surface of A. marginale during the transition from the
tick cell into the mammalian cell [18].
Interestingly, the number of Msp2 superfamily members
such as omp1 to omp15 in A. marginale subsp. centrale, is
reduced in comparison with US A. marginale strains [10].
For example, closely related sequences to omp8 and omp6
are missing and omp10 is found with omp7 and a reduced
omp9 in tandem, which may indicate an important function
of these genes in the pathogenicity of A. marginale.
Based on this, further characterization of these
omp10::himar1 mutants to understand the effects of the
disruption of expression of omp10, 9, 8 and 7 on the
phenotype of A. marginale is of critical importance.
Phenotypic effects may include infectivity, tick transmissi-
bility, stability under non selectable conditions, ability to
induce immune responses and ability to establish persist-
ent infection within the natural host.
Conclusions
Transposon mutagenesis is achievable for A. marginale.
High throughput genome sequencing of recombinant
bacteria electroporated with a single plasmid containing
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insertion of the Himar1 sequences into the omp10 gene
of A. marginale. The insertion was mediated by the
transposase in a cut and paste mechanism. In tick cells
omp10 is expressed as a polycistronic message with
AM1225 at the 5’end and omp9, 8 and 7 at the 3’ end.
Insertion of the Himar 1 transposon within omp10 not
only disrupted its expression but also the expression of
genes downstream, such as omp9, omp8 and omp7.
This work shows the utility of the Himar1 system for
the generation of insertional mutants in A. marginale,
for the identification of genes involved in virulence and
potentially for the development of attenuated organisms.
Methods
A. marginale cultivation
Cultures of A. marginale str. Virginia wild-type and
omp10::himar1 mutant were maintained in tick ISE6
cells derived from embryonated eggs of the blacklegged
tick, Ixodes scapularis at 34°C in non-vented 25-cm2 cell
culture flasks (NUNC). A. marginale-infected cell cultures
were maintained in L15B300 medium supplemented with
5% fetal bovine serum (FBS, BenchMark, Gemini Bio-
Products), 5% tryptose phosphate broth (TPB, Difco,
Becton Dickinson), 0.1% bovine lipoprotein concentrate
(LPC, MP-Biomedical), 0.25% NaHCO3, and 25 mM
HEPES buffer, adjusted to pH 7.8, as previously de-
scribed [49]. The cell culture medium for ISE6 cells
infected with the A. marginale omp10::himar1 mutant
was supplemented with spectinomycin (Sigma Aldrich)
and streptomycin (Sigma Aldrich) to a final concentra-
tion of 50 μg/ml each.
Isolation of the A. marginale mutant by transposon
mutagenesis
To maximize chances of obtaining a transformant using
transposon mutagenesis, we used a single plasmid con-
struct that encoded both the transposon and the trans-
posase in cis configuration as described [50], except that
the fluorescent marker was replaced by sequences en-
coding a monomeric red fluorescent protein, mCherry
[51] (Figure 1A). A. marginale bacteria passaged 53 times
in ISE6 cells were harvested from one 25-cm2 culture in
5 ml of medium when ~80% of cells were infected, and
many cells were undergoing lysis. The cells were recov-
ered in 2 ml of culture medium, and added to a 2-ml
microcentrifuge tube containing 0.3 ml of sterile silicon
carbide abrasive (60/90 grit; Lortone, Inc), vortexed at
maximum speed for 30 sec, and the lysate transferred to a
fresh 2-ml tube on ice. Bacteria were collected by centrifu-
gation at 11,000 g for 10 min at 4°C, and washed twice in
ice-cold 300 mM sucrose. They were then resuspended in
50 μl of 300 mM sucrose containing 3 μg of plasmid
DNA, and incubated on ice for 15 min before beingelectroporated (Biorad Gene Pulser II) at 2 kV, 400 Ohm
and 25 μF in a 0.2 cm gap cuvette. The electroporation
mixture was recovered in 1.5 ml of an ISE6 cell
suspension (~2×106 cells), and centrifuged in a micro-
centrifuge tube at 1,000 g for 10 min at room
temperature. The tube was left undisturbed for 30 min
at room temperature, and the pellet then resuspended
in the supernatant medium and added to a 25-cm2
flask containing ~5×106 ISE6 cells in 3 ml of L15B300
medium supplemented as described for Anaplasma-
infected cultures. The culture was incubated at 34°C
in a tightly capped flask. Three days after electroporation,
the culture medium was replaced with 5 ml of medium
additionally containing 50 μg/ml of spectinomycin and
streptomycin (selection medium). Subsequently, the cul-
ture was fed twice weekly with selection medium and
examined weekly on an inverted microscope (Diaphot,
Nikon) fitted for epifluorescence using a Texas Red filter.
The first fluorescent colonies of bacteria were noted 6 wk
following electroporation, and the culture was maintained
in selection medium with twice-weekly medium changes
until ~90% of cells were infected. At that time, the mutant
was passaged (ten-fold dilution) to fresh cells, and the
remainder was stored in liquid nitrogen.
Preparation of host cell-free A. marginale wild-type and
omp10::himar1 mutant from ISE6 tick cells
Isolation of A. marginale wild-type and omp10::himar1
mutant was performed by disruption of ISE6 tick cells
with 1 mm diameter glass beads (BioSpec Technologies)
in a Minibead beater (BioSpec technologies) as described
elsewhere [52], with the exception that cells were shaken
only once for 10s and immediately placed on ice. Cell ly-
sates were transferred to 1.5 ml centrifuge tubes and
centrifuged at 100 g for 5 min at 4°C to pellet cell debris.
The supernatant was then carefully removed and trans-
ferred to clean 1.5 ml centrifuge tubes. A. marginale
organisms (wild-type and omp10::himar1 mutant) were
pelleted at 11,000 g for 10 min at 4°C, and stored at −20°C.
DNA isolation and Phi29 amplification of the A. marginale
omp10::himar1 mutant
Before DNA isolation, pelleted A. marginale omp10::
himar1 mutants were treated with RNaseA (QIAGEN)
and DNase I (Sigma Aldrich) to remove ISE6 host cell
contaminant nucleic acids. DNA isolation was performed
using the QIAamp DNA Mini kit (QIAGEN) as per man-
ufacturer’s instructions, but in this case the DNA was
eluted in 50 μl of 1 mM Tris pH 9.0. DNA concentration
was determined using the Qubit dsDNA HS assay kit (Life
technologies) on a Qubit fluorometer (Life technologies).
5 reactions of 10 ng of DNA were used for whole genome
amplification using the Genomi Phi V2 DNA amplifica-
tion kit (GE Healthcare) according to manufacturer’s
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together and the DNA purified with GelElute Extraction
Kit (5 PRIME) by adsorption to silica particles and eluted
with 10 mM Tris pH8.2.
Genome sequencing and bioinformatics
Samples from 2.0 to 3.6 μg of amplified DNA derived
from the omp10::himar1 mutant, were provided for library
construction and sequencing by the Roche/454 (GS-FLX)
method to the Interdisciplinary Center for Biotechnology
Research (ICBR) at the University of Florida. Also, sam-
ples of equivalent amounts were provided to the Scripps
Research Institute, La Jolla, California for sequencing by
the Illumina (HiSeq) method.
A total of 374,151 and 207,288,916 reads of Roche/454
and Illumina sequencing data, respectively, were obtained.
The FASTQ files provided by the sequencing facilities
were uploaded to the UF GALAXY web site http://galaxy.
hpc.ufl.edu, and analyzed separately.
Uploaded Illumina FASTQ files were groomed, filtered
and formatted into FASTA files using the FASTQ
Groomer, Filter FASTQ and FASTQ to FASTA converter
tools located in the NGS: QC and manipulation toolbox
of GALAXY. FASTA files were then aligned to the
A. marginale str. St Maries reference genome sequence
(CP000030) using the Megablast alignment tool (NCBI
BLAST + blastn (version 0.0.12) in GALAXY) to obtain
sequencing reads that contained A. marginale sequences.
These A. marginale sequencing reads were then used
for a second Megablast alignment using as a reference
sequence 28 nucleotides from the Himar1 terminal
inverted repeats (TIR). The transposon insertion locus
within the A. marginale chromosome was then deter-
mined, since the reads obtained contained the A. mar-
ginale-Himar1 TIR junctions.
A similar strategy was used for the analysis of the
Roche/454 sequencing reads. CLC genomics workbench,
version 6.5 was used for assemblies of Roche/454 and
Illumina reads.
RNA isolation
For RNA isolation, three samples of ISE6 cells infected
with A. marginale wild-type and three omp10::himar1
samples were used. Each sample derived from separate
cultures grown in T-25 cell culture flasks. Samples con-
taining approximately equal numbers of infected cells
were collected in RNA stabilization reagent RNAlater
(AMBION-Life technologies) and stored at −80°C. Total
RNA was isolated using the RNeasy kit (QIAGEN) with
an added “on-column” DNase I treatment (QIAGEN)
according to manufacturer’s instructions. Aliquots of
extracted RNA were used to measure contaminant DNA
concentration using the Qubit dsDNA HS assay kit (Life
technologies). Additionally, RNA was treated three timeswith RNase-free Dnase I (AMBION-Life technologies) to
remove any trace of contaminant DNA in the sample. RNA
concentration was measured with the Qubit RNA assay kit
(Life technologies), and samples were stored at −80°C.
RT-PCR and RT-qPCR experiments
RNA (2 μg) from ISE6 cells infected with A. marginale
wild-type and omp10::himar1 mutant was converted to
cDNA by random priming using a Omniscript reverse
transcriptase kit (QIAGEN) according to manufacturer’s
conditions. Genomic DNA and no-reverse transcriptase
reactions were included as controls for each sample and
each nucleic acid target. Specific primers (Table 1) were
designed to amplify transcripts from intergenic regions
between omp7-omp8, omp8-omp9, omp9-omp10 and
omp10-AM1225 using cDNA from ISE6 cells infected
with A. marginale wild-type as template. Similarly tran-
scripts from within omp6, omp7, omp8, omp9, and
omp10 genes were detected by PCR amplification of
cDNA from ISE6 cells infected with A. marginale wild-
type and the omp10::himar1 mutant using omp6-10 spe-
cific primers (Table 1). PCR amplification conditions for
each PCR experiment are described in Additional file 1:
Tables S1 and S2 respectively.
RT-qPCR experiments
Transcript differences between omp8, omp9, omp10-5’
end, and omp10-3’ genes in A. marginale wild-type and
omp10::himar1 mutant were determined using the com-
parative 2-ΔΔCt method [53,54] and the results were
based on the mean of three biological samples (individ-
ual RNA extracts). For Taqman quantitative PCR, cDNA
obtained from ISE6 cells infected with A. marginale
wild-type and the omp10::himar1 was used with primers
and probes (Table 1) designed to amplify omp8, omp9,
omp10-5’ end, omp10-3’ end, msp5, rpoH and the 16S
gene sequences. Reaction conditions are described in
Additional file 1: Table S3, specificity of primers and
probes is shown in Additional file 1: Figure S1 and the
amplification efficiencies for each target are reported in
Additional file 1: Table S4. For a valid 2-ΔΔCt calculation,
relative efficiencies of target vs. reference genes were cal-
culated and are reported in Additional file 1: Table S5.
Significant differences between the A. marginale wild-
type and omp10::himar1 mutant were calculated by
Student’s t test (P < 0.05), comparing ΔCt values (target
gene- reference gene) of the omp10::himar1 mutant and
the wild-type. The fold difference was based on ΔΔCt
(omp10::himar1 mean ΔCt – wild-type mean ΔCt) and
calculated as 2-ΔΔCt which yields the expression ratio. The
expression ratio was then expressed as percentage of ex-
pression by multiplying the 2-ΔΔCt values by 100. For
normalization of relative gene expression data msp5 [55],
rpoH, and 16S were used as reference genes.
Table 1 PCR and Taqman qPCR oligonucleotides used in this study
Oligonucleotide sequence (5’ to 3’) Target Size Reference
PCR
AB1553 CTCCAATCGGAGGGGTTGTG omp6 492bp [43]
AB1554 GCATAAATCCAGTTTAGCCTCC
AB1555 GTGGTTAGATCTTTTCTGTTGGG omp7 399bp [43]
AB1556 CGCTCTACCACTGACCTTCATG
AB1591 GCTGGAGTTCGAAGCGATGC omp8 259bp This study
AB1592 CAGAGCGCCCTGTTTCAGTG
AB1559 AGCTGGGGCTCTTGCGTTTG omp9 1096bp [43]
AB1560 AACATATTCACTATAATCTGACGCTGC
AB1561 TCCTTCGGGTTGCTGCGTTG omp10 969bp [43]
AB1562 GCTTACCCCCATTCCAGCAC




AB1592 CAGAGCGCCCTGTTTCAGTG omp8 259bp This study
AB1593 GCGTGAGCACTGCGGTACAGACGG
AB1581 GAAGTCACTACACGACCTGACTGT
AB1582 TAAAGCATCTTCGCGGGTCGT omp9 145bp [43]
AB1583 TATTCAGTGCGCTGAACACTGCGATCCA
AB1594 GTGGGTGCTGTACGCACATT
AB1595 AAAGACAGCAGGCAGCAACA omp10-5' 170bp This study
AB1596 CGCGTGTCCTTCGGGTTGCT
AB1569 GGTGCTGAGTTGAAGCTTGC
AB1570 GCCACAGACCCACTATCAGC omp10-3' 140bp [43]
AB1571 TATCTCGCGCTGCATCGGTG
AB1572 AGGATGATCAGCCACACTGGAA
AB1573 TACAACCCTAAGGCCTTCCTCA 16S 131bp [42]
AB1574 TATTGGACAATGGGCGCAAGCCTGAT
AB1606 CTCACAGGCGAAGAAGCAGAC
AB1607 GCCCGACATACCTGCCTTT msp5 145bp [55]
AB1610 TGGGCGACAAGAAGCCAAGTGA
AB1608 ATCAAAGCTATTGCGGAGGA
AB1607 ACAGAACTCTCCCCATGCAC rpoH 116bp This study
AB1611 TGCCAATCGGGACGTTTCGC
AB1242 AAAACAGGCTTACCGCTCCAA
AB1243 GGCGTGTAGCTAGGCTCAAAGT opag2 151bp [41]
AB1250 CTCTCCTCTGCTCAGGGCTCTGCG
*Primers and TaqMan probes used were manufactured at Eurofins MGM Operon.
Oligonucleotides are labeled with 6-Carboxyfluorescein 6-FAM at the 5’ end and Tetramethylrhodamine TAMRA at the 3’ end.
Crosby et al. BMC Genomics 2014, 15:278 Page 13 of 15
http://www.biomedcentral.com/1471-2164/15/278Western immunoblots
Expression of the Omp9 protein in A. marginale wild-
type and omp10::himar1 mutant was assessed by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis and
immunoblotting using equal amounts (108) of host-freebacteria. Membranes were incubated with three different
antibodies; the anti-Omp9 monoclonal antibody (121/1055)
[43], the monoclonal antibody F16C1 (reacts with the
Msp5 protein and served as a loading control) [56] and the
monoclonal antibody Tryp1E1 (exhibits specificity for a
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This last antibody served as a negative control. Final con-
centrations of each antibody used were 4 μg/ml, 2 μg/ml
and 4 μg/ml. Antibody binding was detected with the sec-
ondary antibody goat anti-mouse IgG, horseradish peroxid-
ase labeled and diluted to 1:10,000 using the Pierce ECL
Western blotting substrate (Thermo scientific) as described
in manufacturer’s instructions.
Quantification of the number of A. marginale wild-
type and omp10::himar1 organisms was performed as
described elsewhere [41].
GenBank accession numbers
for assembled contigs containing the Himar1 transposon
sequences integrated within omp10 and upstream genes
(KJ567138) and omp10 (partial 3’ end) and omp9 genes
(KJ567139).
Additional file
Additional file 1: RT-PCR and RT-qPCR experiments Figure and Tables.
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